Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAlamar Biosciences Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$1.76 | -$1.66 | -$1.71 |
| Q2 2026 | 3 | -$0.34 | -$0.26 | -$0.31 |
| Q3 2026 | 3 | -$0.25 | -$0.17 | -$0.21 |
| Q4 2026 | 1 | -$0.19 | -$0.18 | -$0.18 |
| Q1 2027 | 1 | -$0.19 | -$0.18 | -$0.19 |
| Q2 2027 | 1 | -$0.16 | -$0.15 | -$0.16 |
| Q3 2027 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q4 2027 | 1 | -$0.15 | -$0.14 | -$0.15 |
Alamar Biosciences Inc. Earnings Date And Information
Alamar Biosciences Inc. last posted its earnings results on Friday, May 8th, 2026. The company reported $-1.74 earnings per share for the quarter, missing analysts' consensus estimates of $-1.71 by $0.03. The company had revenue of 26.04 M for the quarter and had revenue of 74.21 M for the year. Alamar Biosciences Inc. has generated $0 earnings per share over the last year ($-0.45 diluted earnings per share) and currently has a price-to-earnings ratio of -50.62. Alamar Biosciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Alamar Biosciences Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/08/2026 | Q1 2026 | -$1.71 | -$0.31 | 1.4 | $26.01 M | $26.04 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alamar Biosciences Inc. Earnings: FAQ's
The conference call for Alamar Biosciences Inc.'s latest earnings report can be listened to online.
The conference call transcript for Alamar Biosciences Inc.'s latest earnings report can be read online.
Alamar Biosciences Inc. (:ALMR) has a recorded annual revenue of $74.21 M.
Alamar Biosciences Inc. (:ALMR) has a recorded net income of $-29,819,000.Alamar Biosciences Inc. has generated $-0.45 earnings per share over the last four quarters.
Alamar Biosciences Inc. (:ALMR) has a price-to-earnings ratio of -50.62 and price/earnings-to-growth ratio is -0.51.